Constantine Nicolaides, MD

Articles by Constantine Nicolaides, MD

Paclitaxel and Carboplatin as First-Line Chemotherapy for Advanced Breast Cancer

ByGeorge Fountzilas, MD,Dimitrios Bafaloukos, MD,Gerasimos Aravantinos, MD,Constantine Nicolaides, MD,Haralambos Kalofonos, MD,Pavlos Papakostas, MD,Nicholaos Xiros, MD,Evalgelia Razi, MD

January 1st 1998

In a phase II study, 66 patients with advanced breast cancer (median age 56 years; range, 28 to 75 years) were treated with paclitaxel (Taxol), 175 mg/m² infused over 3 hours, and carboplatin (Paraplatin), dosed to attain an

Latest Updated Articles

Paclitaxel and Carboplatin as First-Line Chemotherapy for Advanced Breast Cancer
Published: January 1st 1998 | Updated:

Constantine Nicolaides, MD

Articles by Constantine Nicolaides, MD

Paclitaxel and Carboplatin as First-Line Chemotherapy for Advanced Breast Cancer

Latest Updated Articles

Trending on CancerNetwork

Serplulimab Plus Chemo Meets EFS End Point in Early-Stage Gastric Cancer

CD20 Bispecifics vs CAR T: Evaluating CRS and ICANS in Lymphoma

KRd Appears to Exhibit Greater Outcomes in Standard-Risk Multiple Myeloma

ADCE-D01 Earns FDA Fast Track Designation in Soft Tissue Sarcoma

KRd-Based Quadruplets May “Eliminate” Transplant Need for Multiple Myeloma